Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 292

Работа: CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  1. Stem cells and common biomaterials in dentistry: a review study

    Seyed Ali Mosaddad, Boshra Rasoolzade, Reza Abdollahi Namanloo +2

    Обзорная статья2022Цитирований: 8
    ABI

  2. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression

    Yun Feng, Fang Li, Jing Yan +15

    Статья2021Цитирований: 5
    ABI

  3. Global stabilization of the full attraction-repulsion Keller-Segel system

    Hai‐Yang Jin, Zhi‐An Wang

    Статья2019Цитирований: 3
    ABI

  4. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

    Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

    Статья2022Цитирований: 3
    ABI

  5. VEGF as a Key Mediator of Angiogenesis in Cancer

    Peter Carmeliet

    Обзорная статья2005Цитирований: 3
    ABI

  6. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

    M.-s. Jung, Jin Kyung Rho, Y-M Kim +7

    Статья2012Цитирований: 2
    ABI

  7. Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia

    Mohammad Jafari, Farahnaz Dadras, Hamid Reza Ghadimipour +2

    Статья2016Цитирований: 2
    ABI

  8. Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

    Farahnaz Dadras, Vida Sheikh, Farhad Khoshjou

    Статья2017Цитирований: 2
    ABI

  9. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

    Xinbing Sui, Ruonan Zhang, Shuiping Liu +8

    Статья2018Цитирований: 2
    ABI

  10. Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

    Nasrin Fouladi, Maedeh Barahman, Firouz Amani +2

    Статья2019Цитирований: 2
    ABI

  11. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression

    Shuiping Liu, Qiujie Li, Ke Chen +7

    Обзорная статья2020Цитирований: 2
    ABI

  12. <p>Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review</p>

    Jie Li, Jiaqian Zhao, Tiantian Tan +7

    Обзорная статья2020Цитирований: 2
    ABI

  13. Efficient isolation and identification of primary endothelial cells from bovine aorta by collagenase P

    Faezeh Seif, Alireza Kheirollah, Hossein Babaahmadi‐Rezaei

    Статья2020Цитирований: 2
    ABI

  14. Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

    Zeynab Aliyari-Serej, Ayyub Ebrahımı, Tohid Kazemi +4

    Статья2020Цитирований: 2
    ABI

  15. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

    Yuan Gao, Hang Zhang, Frédéric Lirussi +3

    Обзорная статья2020Цитирований: 2
    ABI

  16. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

    Suwen Hu, Zi Hui, Frédéric Lirussi +3

    Обзорная статья2020Цитирований: 2
    ABI

  17. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells

    Xiaolie He, Yanjing Zhu, Li Yang +6

    Статья2021Цитирований: 2
    ABI

  18. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

    Mohamed M Darwish, Atef Youssef Riad, Dina Salem +3

    Статья2021Цитирований: 2
    ABI

  19. Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

    Maryam Khosravian, Mahnaz Momenzadeh, Farzad Koosha +2

    Статья2021Цитирований: 2
    ABI

  20. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

    Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

    Обзорная статья2022Цитирований: 2
    ABI

  21. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Обзорная статья2022Цитирований: 2
    ABI

  22. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

    Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

    Обзорная статья2022Цитирований: 2
    ABI

  23. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

    Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

    Статья2022Цитирований: 2
    ABI

  24. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

    Amid Yazdani, Farshad Namdari, Sattar Gorgani‐Firuzjaee +1

    Статья2022Цитирований: 2
    ABI

  25. Survival rates and prognostic factors of thyroid cancer: A retrospective cohort study

    Ali Amri, Ali Reza Soltanian, Shiva Borzouei

    Статья2022Цитирований: 2
    ABI